| 0 (0%) | 09-27 11:11 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 38.37 | 1-year : | 39.05 |
| Resists | First : | 32.85 | Second : | 33.43 |
| Pivot price | 32.18  |
|||
| Supports | First : | 31.9 | Second : | 26.54 |
| MAs | MA(5) : | 32.04 | MA(20) : | 32.26 |
| MA(100) : | 31.72  |
MA(250) : | 30.84 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 20.4 | D(3) : | 20.3 |
| RSI | RSI(14): 42.8 | |||
| 52-week | High : | 33.43 | Low : | 27.47 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CIZ ] has closed above bottom band by 30.2%. Bollinger Bands are 53% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 32.12 - 32.28 | 32.28 - 32.41 |
| Low: | 31.6 - 31.82 | 31.82 - 32 |
| Close: | 31.74 - 32.07 | 32.07 - 32.34 |
Wed, 16 Jul 2025
Council leans towards safety in review of licensing policy - Brighton and Hove News
Thu, 22 May 2025
TAG Heuer CMO George Ciz on What The Brand’s Return as Official Timekeeper for Formula One Means - Prestige Hong Kong
Mon, 31 Mar 2025
Tag Heuer shifts marketing focus amid wider transformation - Marketing Week
Thu, 02 Jan 2025
Cizzle Biotechnology's shares rise 5% on senior appointment and progress report - Proactive Investors
Mon, 16 Dec 2024
RNS Hotlist with Zak Mir: BEM, INT, OMI, AURA, CRTA, OBD, CIZ, ARV, TERN, SEEN, PHE, BHL, QED, ALL, EDX & VLRM - Share Talk
Fri, 25 Oct 2024
Cizzle Biotechnology’s Dr Allan Syms on CIZ1B Biomarker, Partnerships and Future Plans (LON:CIZ) - DirectorsTalk Interviews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|